Comparison of in vitro and in vivo developmental toxicity and pharmacokinetics of phenytoin in the rat

Pharmacology and Toxicology

Volumn 87, Issue 2, 2000, Pages 96-102

  Beekhuijzen, Manon E W ^a   Verhoef, Aart ^a   Klaassen, Rob ^a   Rompelberg, Cathy J M ^a   Piersma, Aldert H ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; PHENYTOIN;

ANIMAL MODEL; ANTICONVULSANT THERAPY; ARTICLE; CONGENITAL MALFORMATION; DRUG BLOOD LEVEL; EMBRYO CULTURE; EMBRYO DEVELOPMENT; EMBRYOTOXICITY; FEMALE; GESTATIONAL AGE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0033900805     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0773.2000.d01-51.x     Document Type: Article

References (24)

1. Bechter, R. & H. Schön: Use of the whole embryo culture system in drug safety assessment? Toxicology in vitro 1988, 2, 195-203.
2. Brown, N. A. & S. Fabro: Quantitation of rat embryonic development in vitro: a morphological scoring system. Teratology 1981, 24, 65-78.
3. Bruckner, A., Y. J. Lee, K. S. O'Shea & R. C. Henneberry: Teratogenic effects of valproic acid and diphenylhydantoin on mouse embryos in culture. Teratology 1983, 27, 29-42.
4. Cicurel, L. & B. P. Schmid: Postimplantation embryo culture for the assessment of the teratogenic potential and potency of compounds. Experientia 1988, 44, 833-840.
5. Della Paschoa, O. E., J. W. Mandema, R. A. Voskuyl & M. Danhof: Pharmacokinetic-pharmacodynamic modeling of the anticonvulsant and electroencephalogram effects of phenytoin in rats. J. Pharmacol. Exp. Therap. 1998, 284, 460-466.
6. Eadie, M. J., J. H. Tyrer, F. Bochner & W. D. Hooper: The elimination of phenytoin in man. Clin. Exp. Pharmacol. Physiol. 1976, 3, 217-224.
7. Eadie, M. J.: Formation of active metabolites of anticonvulsant drugs. A review of their pharmacokinetic and therapeutic significance. Clin. Pharmaacokin. 1991, 21, 27-41.
8. Finnell, R. H. & G. F. Chernoff: Variable patterns of malformation in the mouse fetal hydantoin syndrome. Amer. J. Med. Genet. 1984, 19, 463-471.
9. Finnell, R. H. & L. V. Dansky: Parental epilepsy, anticonvulsant drugs, and reproductive outcome: epidemiologic and experiental findings spanning three decades; 1: Animal studies. Reprod. Toxicol. 1991, 5, 281-299.
10. Hanson, J. W. & D. W. Smith: The fetal hydantoin syndrome. J. Pediatr. 1975, 87, 285-290.
11. Hendrie, T. A., J. R. Rowland & P. E. Binkerd: Developmental toxicity and pharmacokinetics of phenytoin in the rhesus macaque: an interspecies comparison. Reproduct. Toxicol. 1990, 4, 257-266.
12. Jung, D.: Effect of dose on phenytoin absorption. Clin. Pharmacol. Ther. 1980, 28, 479-485.
13. Liu, L. & P. G. Wells: Potential molecular targets mediating chemical teratogenesis: in vitro peroxidase-catalyzed phenytoin metabolism and oxidative damage to proteins and lipids in murine maternal hepatic microsomes and embryonic 9000 g supernatant. Toxicol. Appl. Pharmacol. 1995, 134, 71-80.
14. Lindhout, D., J. W. A. Meijer, A. Verhoef & P. W. J. Peters: Metabolic interactions in clinical and experimental teratogenesis. Eds. H. Nau & W. J. Scott. CRC Press 1987, pp. 233-250.
15. Lorente, C. A., M. S. Tassinari & D. A. Keith: The effects of phenytoin on rat development: an animal model system for fetal hydantoin syndrome. Teratology 1981, 24, 169-180.
16. New, D. A. T.: Whole embryo culture and study of mammalian embryos during organogenesis. Biol. Rev. 1978, 53, 81-122.
17. Ozolins, T. R., M. J. Wiley & P. G. Wells: Phenytoin covalent binding and embryopathy in mouse embryos co-cultured with maternal hepatocytes from mouse, rat and rabbit. Biochem. Pharmacol. 1995, 50, 1831-1840.
18. Peters, P. W. J.: Double staining of fetal skeletons for cartilage and bone. In: Methods in prenatal toxicology. Ed. D. Neubert et al. George Thieme Publ., Stuttgart. 1977, pp. 153-154.
19. Piersma, A. H., P. Attenon, R. Bechter, M. J. Govers, N. Krafft, B. P. Schmid, J. Stadler, A. Verhoef & C. Verseil: Interlaboratory evaluation of embryotoxicity in the postimplantation rat embryo culture. Reproduct. Toxicol. 1995, 9, 275-280.
20. Piersma, A. H., R. Bechter, N. Krafft, B. P. Schmid, J. Stadler, A. Verhoef, C. Verseil & J. Zijlstra: Interlaboratory validation of five pairs of teratogens and non-teratogens in postimplantation rat embryo culture. ATLA 1996, 24, 201-209.
21. Rosenberg, J., N. L. Benowitz & S. Pond: Pharmacokinetics of drug overdose. Clin. Pharmacokin. 1981, 6, 161-192.
22. Rowland, J. R., P. E. Binkerd & A. G. Hendrickx: Developmental toxicity and pharmacokinetics of oral and intravenous phenytoin in the rat. Reproduct. Toxicol. 1990, 4, 191-202.
23. Schmid, B. P.: Teratogenicity testing of new drugs with the postimplantation embryo culture system. Concepts Toxicol. 1985, 3, 46-57.
24. Wilson, J. G.: Methods for administering agents and detecting malformations in experimental animals. In: Teratology: Principles and techniques. Ed.: J. G. Wilson & J. Warkany. University of Chicago Press, Chicago, Illionois. 1965, pp 262-277.